DIAGN MICROBIOLINFECTDIS 1990;13:57-61
57
In vitro Activity of Meropenem (SM-7338), Imipenem, and Five Other Antibiotics Against Anaerobic Clinical Isolates Patrick R. Murray and Ann C. Niles
The in vitro susceptibility of 513 recent anaerobic clinical isolates was evaluated against meropenem (SM-7338), a new carbapenem, and six other antibiotics. Virtually all Gram-positive and Gram-negative anaerobic bacteria tested were susceptible to meropenem (defined as MICs ~ 8 IJ,g/ml) with 99.8% of the isolates inhibited by. 128 128 .015-8 .06-128 .06-> 128 128 .06->128 .06-> 128 128 .03-16 .015-32 .008->128 ~
57
In vitro Activity of Meropenem (SM-7338), Imipenem, and Five Other Antibiotics Against Anaerobic Clinical Isolates Patrick R. Murray and Ann C. Niles
The in vitro susceptibility of 513 recent anaerobic clinical isolates was evaluated against meropenem (SM-7338), a new carbapenem, and six other antibiotics. Virtually all Gram-positive and Gram-negative anaerobic bacteria tested were susceptible to meropenem (defined as MICs ~ 8 IJ,g/ml) with 99.8% of the isolates inhibited by. 128 128 .015-8 .06-128 .06-> 128 128 .06->128 .06-> 128 128 .03-16 .015-32 .008->128 ~
